Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms

European Journal of Pharmacology

Volumn 491, Issue 1, 2004, Pages 31-36

  Murakawa, Kaoru ^a   Hirose, Noriya ^a   Takada, Koji ^a   Suzuki, Tsutomu ^b   Nagase, Hiroshi ^c   Cools, Alexander R ^d   Koshikawa, Noriaki ^a  

^a NIHON UNIVERSITY   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c Pharmaceutical Research Laboratories   (Japan)

^d RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Deltorphin II; Extracellular dopamine; Nucleus accumbens; Opioid receptor; Tetrodotoxin

Indexed keywords

DELTA OPIATE RECEPTOR; DELTORPHIN; DOPAMINE; MU OPIATE RECEPTOR; NALOXONE; NALTRIBEN; OPIATE RECEPTOR; TETRODOTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG EFFECT; DRUG MECHANISM; EXTRACELLULAR SPACE; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; ANIMALS; BENZYLIDENE COMPOUNDS; DOPAMINE; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NUCLEUS ACCUMBENS; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; SOMATOSTATIN; TETRODOTOXIN; TIME FACTORS;

EID: 16544368799     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.03.028     Document Type: Article

References (33)

1. Benveniste H., Hansen A.J., Ottosen N.S. Determination of brain interstitial concentrations by microdialysis. J. Neurochem. 52:1989;1741-1750.
2. Broekkamp C.L.E., Phillips A.G., Cools A.R. Stimulant effects of enkephalin microinjection into the dopaminergic A10 area. Nature. 278:1979;560-562.
3. Devine D.P., Leone P., Pocock D., Wise R.A. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266:1993;1236-1246.
4. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 85:1988;5274-5278.
5. Di Chiara G., Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080.
6. Erspamer V., Melchiorri P., Falconieri-Erspamer G., Negri L., Corsi R., Severini C., Barra D., Simmaco M., Kreil G. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc. Natl. Acad. Sci. U. S. A. 86:1989;5188-5192.
7. Fairbrother I.S., Arbuthnott G.W., Kelly J.S., Butcher S.P. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine. J. Neurochem. 54:1990;1844-1851.
8. Kischka U., Farber S.A., Marshall D., Wurtman R.J. Carbachol and naloxone synergistically elevate dopamine release in rat striatum: an in vivo microdialysis study. Brain Res. 613:1993;288-290.
9. Kosterlitz H.W. The Wellcome Foundation lecture, 1982. Opioid peptides and their receptors. Proc. R. Soc. Lond., B. Biol. Sci. 225:1985;27-40.
10. Kramer T.H., Shook J.E., Kazmierski W., Ayres E.A., Wire W.S., Hruby V.J., Burks T.F. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo. J. Pharmacol. Exp. Ther. 249:1989;544-551.
11. Kreil G., Barra D., Simmaco M., Erspamer V., Erspamer G.F., Negri L., Severini C., Corsi R., Melchiorri P. Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors. Eur. J. Pharmacol. 162:1989;123-128.
12. Latimer L.G., Duffy P., Kalivas P.W. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J. Pharmacol. Exp. Ther. 241:1987;328-337.
13. Lee P.H., McNutt R.W., Chang K.-J. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat. J. Pharmacol. Exp. Ther. 267:1993;883-887.
14. Leone P., Pocock D., Wise R.A. Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol. Biochem. Behav. 39:1991;469-472.
15. Lindefors N., Amberg G., Ungerstedt U. Intracerebral microdialysis: I. Experimental studies of diffusion kinetics. J. Pharmacol. Methods. 22:1989;141-156.
16. 1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens. J. Neurosci. 11:1991;1565-1576.
17. Murai T., Koshikawa N., Kanayama T., Takada K., Tomiyama K., Kobayashi M. Opposite effects of midazolam and (β-carboline-3-carboxylate ethyl ester on the release of dopamine from rat nucleus accumbens measured by in vivo microdialysis. Eur. J. Pharmacol. 261:1994;65-71.
18. O'Neill S.J., Collins M.A., Pettit H.O., McNutt R.W., Chang K.-J. Antagonistic modulation between the delta opioid agonist BW373U86 and the mu opioid agonist fentanyl in mice. J. Pharmacol. Exp. Ther. 282:1997;271-277.
19. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 4th edn. 1998;Academic Press, New York.
20. Pelton J.T., Kazmierski W., Gulya K., Yamamura H.I., Hruby V.J. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for μ opioid receptors. J. Med. Chem. 29:1986;2370-2375.
21. Pentney R.J.W., Gratton A. Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: an in vivo electrochemical study. Neuroscience. 45:1991;95-102.
22. Pontieri F.E., Tanda G., Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. U. S. A. 92:1995;12304-12308.
23. Portoghese P.S. An approach to the design of receptor-type-selective non-peptide antagonists of peptidergic receptors: δ opioid antagonists. J. Med. Chem. 346:1991;1757-1762.
24. Rothman R.B., Westfall T.C. Allosteric coupling between morphine and enkephalin receptors in vitro. Mol. Pharmacol. 21:1982;548-557.
25. Spanagel R., Herz A., Shippenberg T.S. The effects of opioid peptide on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55:1990;1734-1740.
26. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U. S. A. 89:1992;2046-2050.
27. Stiller C.O., Bergquist J., Beck O., Ekman R., Brodin E. Local administration of morphine decreases the extracellular level of GABA in the periaqueductal gray matter of freely moving rats. Neurosci. Lett. 209:1996;165-168.
28. Takada K., Murai T., Kanayama T., Koshikawa N. Effects of midazolam and flunitrazepam on the release of dopamine from rat striatum measured by in vivo microdialysis. Br. J. Anaesth. 70:1993;181-185.
29. Thorat S.N., Hammond D.L. Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat. J. Pharmacol. Exp. Ther. 283:1997;1185-1192.
30. Tomiyama K., Noguchi M., Koshikawa N., Kobayashi M. YM-09151-2 but not l-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism. J. Neurochem. 60:1993;1690-1695.
31. Tomiyama K., Koshikawa N., Funada K., Oka K., Kobayashi M. In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum. J. Neurochem. 65:1995;2790-2795.
32. Vaught J.L., Takemori A.E. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J. Pharmacol. Exp. Ther. 208:1979;86-90.
33. Yoshida Y., Koide S., Hirose N., Takada K., Tomiyama K., Koshikawa N., Cools A.R. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu-and delta-2-opioid receptors. Neuroscience. 92:1999;1357-1365.